What is the typical prescription for a urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment Options for Urinary Tract Infections (UTIs)

For uncomplicated UTIs in women, first-line treatments include nitrofurantoin, fosfomycin trometamol, or trimethoprim-sulfamethoxazole, with the choice depending on local antibiotic resistance patterns. 1

First-Line Treatment Options

For Women with Uncomplicated Cystitis:

  • Fosfomycin trometamol: 3g single dose 1, 2
  • Nitrofurantoin macrocrystals: 50-100mg four times daily for 5 days 1
  • Nitrofurantoin monohydrate/macrocrystals: 100mg twice daily for 5 days 1
  • Trimethoprim-sulfamethoxazole: 160/800mg twice daily for 3 days (if local E. coli resistance is <20%) 1, 3
  • Pivmecillinam: 400mg three times daily for 3-5 days 1

For Men with UTIs:

  • Trimethoprim-sulfamethoxazole: 160/800mg twice daily for 7 days 1
  • Fluoroquinolones may be prescribed based on local susceptibility testing 1

Treatment Selection Considerations

Patient Factors:

  • Pregnancy status: Avoid trimethoprim in first trimester and trimethoprim-sulfamethoxazole in last trimester 1
  • Renal function: Adjust dosing for impaired renal function 3
  • History of recurrent UTIs: Consider obtaining urine culture before initiating treatment 1

Pathogen Considerations:

  • Local resistance patterns should guide empiric therapy choice 1, 4
  • For multidrug-resistant organisms, consider fosfomycin, nitrofurantoin, or carbapenems based on susceptibility 1, 4

Duration of Treatment

  • Uncomplicated cystitis in women: Short-course therapy (1-5 days depending on agent) 1
  • UTIs in men: 7-day course typically recommended 1
  • Complicated UTIs: Generally treated for 7-14 days 3

Special Situations

Recurrent UTIs:

  • Diagnose via urine culture 1
  • Consider non-antimicrobial preventive measures first:
    • Increased fluid intake 1
    • Vaginal estrogen in postmenopausal women 1
    • Immunoactive prophylaxis 1
    • Methenamine hippurate 1, 5
  • If non-antimicrobial interventions fail, consider antimicrobial prophylaxis 1

Treatment Failure:

  • Obtain urine culture and antimicrobial susceptibility testing 1
  • Assume the infecting organism is not susceptible to the original agent 1
  • Retreat with a 7-day regimen using a different antimicrobial agent 1

Common Pitfalls to Avoid

  • Treating asymptomatic bacteriuria (except in pregnancy or before urologic procedures) 1
  • Performing surveillance urine testing in asymptomatic patients with recurrent UTIs 1
  • Using fluoroquinolones as first-line therapy due to increasing resistance rates and risk of adverse effects 4, 5
  • Prescribing overly long courses of antibiotics, which can increase resistance without improving outcomes 1, 6

Evidence Quality Considerations

  • The recommendation for nitrofurantoin is supported by randomized controlled trials showing superior efficacy compared to placebo 7
  • Single-dose fosfomycin shows comparable clinical efficacy to multi-day regimens of other antibiotics, with the advantage of improved compliance 2, 5
  • The optimal duration of nitrofurantoin treatment remains somewhat controversial, with UK guidelines recommending 3 days while some evidence suggests 5 days may be more appropriate 8, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fosfomycin Treatment for Uncomplicated Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nitrofurantoin: what is the evidence for current UK guidance?

The Journal of antimicrobial chemotherapy, 2023

Research

Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women.

The British journal of general practice : the journal of the Royal College of General Practitioners, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.